Ignite Creation Date:
2025-12-25 @ 4:42 AM
Ignite Modification Date:
2026-01-21 @ 11:24 PM
Study NCT ID:
NCT00323518
Status:
COMPLETED
Last Update Posted:
2016-04-13
First Post:
2006-05-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
Sponsor:
CuraGen Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-05
Start Date Type:
None
Primary Completion Date:
2008-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-08
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-08
First Submit QC Date:
None
Study First Post Date:
2006-05-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-03-15
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-03-14
Last Update Post Date:
2016-04-13
Last Update Post Date Type:
ESTIMATED